CDs can form inclusion complexes with cholesterol, in which the cholesterol molecule is trapped inside the CD cavity. This complexation enhances cholesterol’s solubility, facilitating its removal from the body.
An Australian biopharmaceutical company has produced liquid suppositories of Beta-Cyclodextrin, which remove cholesterol from damaged and narrowed arteries after a few months of treatment, increasing blood flow. Cyclodextrins are cage-like molecules with significant applications in many industrial sectors, such as medicine, food, agriculture, the environment, and chemistry.
Cyclodextrins (CD) have shown the potential to effectively treat atherosclerotic plaques in mice by solubilizing plaque cholesterol. Research by the University of Texas Southwest Medical Center shows that treating mice with cyclodextrin significantly prolonged their lives.
Cyclodextrins increase blood circulation. Blood circulation delivers oxygen and nutrients to every part of the body and collects carbon dioxide and other metabolic products to be excreted from the body.
The main vessels clog with cholesterol, and the microscopic vessels are restricted, degrading the body as it ages.